Date: August 15, 2026

Disinvestment / Strategic Actions

  • RPG Life Sciences Limited has completed the transfer of its Active Pharmaceuticals Ingredients (API) Business to RPG Active Pharma Limited, its wholly owned subsidiary
  • The transfer was executed on a slump sale basis as per the Business Transfer Agreement (BTA)
  • The transaction effective date is August 15, 2026
  • This completion intimation follows the company's initial disclosure letter dated July 29, 2026 regarding the execution of the Business Transfer Agreement
  • The disclosure is made under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

Other Operational / Legal / Strategic Disclosures

  • The company submitted this intimation to both National Stock Exchange of India Limited and BSE Limited for information and dissemination